Acute and Chronic Effects of Aminoglycosides on Cochlear Hair Cells
Article first published online: 6 FEB 2006
Annals of the New York Academy of Sciences
Volume 884, OTOTOXICITY: Basic Science and Clinical Applications pages 60–68, November 1999
How to Cite
ARAN, J.-M., ERRE, J.-P., DA COSTA, D. L., DEBBARH, I. and DULON, D. (1999), Acute and Chronic Effects of Aminoglycosides on Cochlear Hair Cells. Annals of the New York Academy of Sciences, 884: 60–68. doi: 10.1111/j.1749-6632.1999.tb08636.x
- Issue published online: 6 FEB 2006
- Article first published online: 6 FEB 2006
ABSTRACT: The first detectable effect on the auditory system after a single high-dose injection of an aminoglycosidic antibiotic (AA) like gentamicin (GM) is the reversible blockade of medial efferent function, probably via blockade of calcium channels at the base of the outer hair cells (OHC). The kinetics of this effect are compatible with that of the molecule in perilymph. In the course of chronic treatment with lower doses, however, ototoxicity develops only after several days of treatment. Still GM can be observed inside the OHCs as soon as 24 hours after the first injection, and will be still present in some OHCs as long as 11 months after a chronic, nonototoxic 6-day treatment.
In vitro, the short-term viability of isolated OHCs is not affected by exposure to AAs, but their transduction channels and their response to acetylcholine are reversibly blocked. However, developing organs of Corti in culture are highly and rapidly affected by exposure to AAs. Yet during direct intracochlear perilymphatic perfusion of GM, 2-mM solutions are not ototoxic, and with perfusion with a 20-mM solution ototoxicity develops only after several days of perfusion.
From these various observations one can describe some aspects of the mechanisms of ototoxicity of AAs, from their access to perilymph and endolymph, to penetration in the hair cells, likely via endocytosis at their apical pole, and intracellular cytotoxic events.